GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 355 filers reported holding GUARDANT HEALTH INC in Q1 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,868,677 | -15.1% | 96,784 | +2.5% | 0.02% | -34.4% |
| Q2 2023 | $3,380,844 | +51.2% | 94,437 | -1.0% | 0.03% | +39.1% |
| Q1 2023 | $2,236,176 | -16.6% | 95,400 | -3.2% | 0.02% | -23.3% |
| Q4 2022 | $2,679,716 | -53.1% | 98,519 | -7.1% | 0.03% | -57.1% |
| Q3 2022 | $5,710,000 | +33.7% | 106,082 | +0.2% | 0.07% | +42.9% |
| Q2 2022 | $4,270,000 | -39.1% | 105,840 | -0.0% | 0.05% | -31.9% |
| Q1 2022 | $7,014,000 | -34.0% | 105,891 | -0.4% | 0.07% | -30.1% |
| Q4 2021 | $10,630,000 | -10.5% | 106,278 | +11.9% | 0.10% | -19.5% |
| Q3 2021 | $11,877,000 | +22.8% | 95,007 | +22.0% | 0.13% | +19.6% |
| Q2 2021 | $9,668,000 | +3.5% | 77,851 | +27.2% | 0.11% | -10.8% |
| Q1 2021 | $9,345,000 | +92.3% | 61,218 | +62.4% | 0.12% | +73.9% |
| Q4 2020 | $4,859,000 | +114.7% | 37,705 | +86.2% | 0.07% | +76.9% |
| Q3 2020 | $2,263,000 | – | 20,247 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |